Impact of haart on causes of death of persons with late-stage AIDS
- 42 Downloads
The increasing use of highly active antiretroviral therapies (HAARTs) has changed the course of AIDS-related illnesses and enhanced the quality of life of patients infected with human immunodeficiency virus (HIV) and may have changes the causes of deaths in patients with acquired immunodeficiency syndrome (AIDS).
The aim of the present study was to investigate causes of deaths in long-term care hospital patients with late-stage AIDS who expired at the Coler-Goldwater Memorial Hospital in New York City in 1995, and in 1998 and 1999, that is, immediately before and the two most recent years after the advent of HAART.
Analysis of causes of deaths as recorded on the death certificates of 232 AIDS patients.
The overall mortality rate declined from 75.6 deaths per 100 person-years in 1995 to 33.2 deaths per 100 person-years in 1998–1999 (P<.001) The number of AIDS patients who expired because of sepsis and opportunistic infections, which includedPneumocystis carinii Pneumonia (PCP), decreased significantly from 30 (26.1%) and 24 (20.9%) in 1995 to 15 (12.8%) and 10 (8.5%) in 1998–1999, respectively (P<.05). In contrast, deaths from hepatic failure increased from 0(0%) in 1995 to 7 (6%) in 1998–1999 (P<.05). Increases, although not significant statistically, were associated with pneumonias excluding PCP, end-stage AIDS, renal failure, and malignancies. Analysis of cause-specific mortality by gender between 1995 and 1998–1999 revealed very little difference between men and women. This analysis showed, however, that the infectious processes taken together (pneumonias excluding PCP, sepsis, and opportunistic infections including PCP) were significantly less frequent causes of death in 1998–1999 than in 1995 (P<.01).
These findings indicate that HAART affected the causes of deaths in patients with AIDS, with “traditional” opportunistic infections diminishing in importance relative to chronic medical conditions and malignancies.
Key WordsDeath HAART Hepatic Failure Late-Stage AIDS Opportunistic Infections Sepsis
Unable to display preview. Download preview PDF.
- 2.Hogg RS, Heath KC, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretrovira therapy.JAMA 1998;11:450–454.Google Scholar
- 4.Chiasson MA, Berenson L, Li W, et al. Declining AIDS mortality in New York City.J. Acquir Immune Defic Syndr Hum Retrovirol 1998;21:59–64.Google Scholar
- 5.Centers for Disease Control and Prevention.HIV/AIDS Surveillance Report. Estimated Incidence of AIDS and Deaths of Persons with AIDS, Adjusted for Delays in Reporting, by Quarter-Year of Diagnosis/Death. United States. January 1985-June 1997. Atlanta, GA: Centers for Disease Control and Prevention; 1997;9:1–44.Google Scholar
- 13.Macdonald JC, Torriani FJ, Morse LS, et al. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.J Infect Dis. 1998;177:1182–1187.PubMedGoogle Scholar
- 18.Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.Ann Intern Med. 1995; 125:933–936.Google Scholar
- 19.Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance definition for AIDS among adolescents and adults.NMWR Morb Mortal Wkly Rep. 1992;41:1–19.Google Scholar
- 20.Glantz SA, Primer of biostatistics, New York: McGraw-Hill, Health Professions Division; 1992.Google Scholar
- 22.Dore GJ, Hoy JF, Mallal SA, et al. Trends in incidence of AIDS illnesses in Australia 1983–1994: the Australian AIDS cohort.J. Acquir Immune Defic Syndr. 1997;16:39–43.Google Scholar
- 24.Metz SA, Hutchins GM, Bacellar H, et al. A comparison of autopsy and death certificates findings among AIDS-related deaths in the Multicenter AIDS Cohort Study.Int Conf AIDS. 1993;9:659.Google Scholar
- 25.Bigger RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms.Hematol Oncol Clin North Am. 1996;10:997–1010.Google Scholar
- 27.Wistuba II, Behrens C, Gazdar AF. Pathogenesis of non-AIDS-defining cancers: a review.AIDS Pat Care STDs. 1999;13:415–426.Google Scholar